Invesco DB Commodity Index Tracking Fund vs DENTSPLY SIRONA Inc — how do they compare? Invesco DB Commodity Index Tracking Fund trades at $32.96 (market cap $1.92B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: Invesco DB Commodity Index Tracking Fund and DENTSPLY SIRONA Inc are close in size by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Invesco DB Commodity Index Tracking Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco DB Commodity Index Tracking Fund for 60 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| DBC | XRAY | |
|---|---|---|
Market Cap | $1.92B | $1.73B |
Volume | 1,375,556 | 6,198,582 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $33.68 | $14.68 |
52-Week Low | $22.07 | $8.52 |
Typical Hold Time | 60 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
DBC trades at $32.96, up 1.38% with a bullish technical signal from moving averages. The company reported $82.59M revenue and $22.38M net income for 2024, showing improved profitability from 2023's loss. Strong cash flow from operations of $431.54M supports a healthy balance sheet with $1.28B equity and minimal debt.
Outlook remains positive with technical momentum and fundamental recovery, though revenue volatility and asset base contraction from $2.7B in 2021 to $1.3B in 2024 present execution risks. Analyst sentiment is bullish with 16 buy signals, but investors should monitor revenue sustainability amid declining assets.
DENTSPLY SIRONA (XRAY) trades at $8.69, down 1.76% on the day and near a 52-week low, reflecting ongoing operational challenges. The stock shows a bearish technical trend with weak moving averages, while fundamentals reveal declining revenue, negative net income margins, and elevated debt levels. Recent Q2 2026 earnings beat expectations but sales fell 4.1%, indicating persistent headwinds in dental markets.
The outlook remains cautious due to margin pressure and competitive threats, though analyst consensus suggests upside to a $13.40 price target. Key risks include execution of the turnaround plan, macroeconomic sensitivity, and high leverage. Investment appeal hinges on successful restructuring and recovery in core dental segments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.
Read more on DBC →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →